Our group focuses on the application of genome and proteome-level targeted technologies to address biological questions in cancer. We are also intrigued by the rapid mutability and genomic plasticity of the cancer genome, and believe that developing whole genome cartographies of tumors will enable us to better understand the molecular basis of cancer and to identify cellular pathways and molecular nodes for intervention.